PL93998B1 - Alkanolamine derivatives[ca945172a] - Google Patents

Alkanolamine derivatives[ca945172a] Download PDF

Info

Publication number
PL93998B1
PL93998B1 PL1970174445A PL17444570A PL93998B1 PL 93998 B1 PL93998 B1 PL 93998B1 PL 1970174445 A PL1970174445 A PL 1970174445A PL 17444570 A PL17444570 A PL 17444570A PL 93998 B1 PL93998 B1 PL 93998B1
Authority
PL
Poland
Prior art keywords
radical
carbon atoms
compound
general formula
alkyl
Prior art date
Application number
PL1970174445A
Other languages
English (en)
Polish (pl)
Original Assignee
Imperial Chemical Industries Ltd Londen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB47048/69A external-priority patent/GB1285038A/en
Application filed by Imperial Chemical Industries Ltd Londen filed Critical Imperial Chemical Industries Ltd Londen
Publication of PL93998B1 publication Critical patent/PL93998B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
    • C07C243/26—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C243/30—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • C07C243/32—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/54—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition of compounds containing doubly bound oxygen atoms, e.g. esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/62—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL1970174445A 1969-02-21 1970-02-11 Alkanolamine derivatives[ca945172a] PL93998B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB47048/69A GB1285038A (en) 1969-02-21 1969-02-21 Alkanolamine derivatives
GB944569 1969-02-21

Publications (1)

Publication Number Publication Date
PL93998B1 true PL93998B1 (en) 1977-07-30

Family

ID=26242944

Family Applications (3)

Application Number Title Priority Date Filing Date
PL1970174450A PL87019B1 (en) 1969-02-21 1970-02-11 Alkanolamine derivatives[ca945172a]
PL1970174445A PL93998B1 (en) 1969-02-21 1970-02-11 Alkanolamine derivatives[ca945172a]
PL1970138762A PL77781B1 (en) 1969-02-21 1970-02-11 Alkanolamine derivatives[ca945172a]

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL1970174450A PL87019B1 (en) 1969-02-21 1970-02-11 Alkanolamine derivatives[ca945172a]

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1970138762A PL77781B1 (en) 1969-02-21 1970-02-11 Alkanolamine derivatives[ca945172a]

Country Status (20)

Country Link
JP (2) JPS535287B1 (es)
AT (3) AT303005B (es)
BE (1) BE746107A (es)
CA (1) CA945172A (es)
CH (3) CH553747A (es)
CS (3) CS153069B2 (es)
DE (1) DE2007751C2 (es)
DK (1) DK135278B (es)
ES (1) ES376788A1 (es)
FI (1) FI53120C (es)
FR (1) FR2034561A1 (es)
IE (1) IE34003B1 (es)
IL (1) IL33931A (es)
KE (1) KE2582A (es)
NL (1) NL162363C (es)
NO (1) NO128653B (es)
PL (3) PL87019B1 (es)
SE (1) SE391517B (es)
SU (3) SU482943A3 (es)
YU (4) YU34275B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1311521A (en) * 1970-02-13 1973-03-28 Ici Ltd Alkanolamine derivatives
DE2048838A1 (de) * 1970-10-05 1972-04-06 C H Boehnnger Sohn, 6507 Ingel heim Neue 1 Phenoxy 2 hydroxy 3 hydroxyal kylaminopropane und Verfahren zu ihrer Her stellung
FR2132570B1 (es) * 1971-04-09 1974-08-02 Lipha
GB1387630A (en) * 1971-05-07 1975-03-19 Ici Ltd Phenoxyalkanolamine derivatives
GB1433595A (en) * 1972-07-06 1976-04-28 Ici Ltd Alkanolamine derivatives
DE2623314C2 (de) * 1976-05-25 1984-08-02 Hoechst Ag, 6230 Frankfurt 1-Aryloxy-2-Hydroxy-3-aminopropane, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2818999A1 (de) * 1978-04-29 1979-11-15 Basf Ag Aminoderivate von 3-alkyl-5-(2- hydroxystyryl)-isoxazolen
DE2943405A1 (de) 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen Neue aminoderivate des 5-(2-hydroxystyryl)-isoxazols
US4593119A (en) * 1980-11-28 1986-06-03 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
JPS57105206U (es) * 1980-12-16 1982-06-29
DE3407695A1 (de) * 1984-03-02 1985-09-12 Röhm Pharma GmbH, 6108 Weiterstadt Pteridinverbindungen mit pharmazeutischer wirksamkeit
DE3500761A1 (de) * 1985-01-11 1986-09-04 SOUR "PODRAVKA" OOUR "BELUPO 2", Proizvodnja kozmetičkih preparata i lijekova, Koprivnica Verfahren zur gewinnung von atenolol und seiner derivate
US4971959A (en) * 1987-04-14 1990-11-20 Warner-Lambert Company Trisubstituted phenyl analogs having activity for congestive heart failure
EP0673924A4 (en) * 1992-12-10 1996-04-24 Teikoku Chem Ind Co Ltd PROPRIONIC ACID DERIVATIVE.
JP2001524114A (ja) * 1997-04-30 2001-11-27 イーライ・リリー・アンド・カンパニー ベンゾ［ｂ］チオフェン類の製造における中間体および方法
JP5225574B2 (ja) * 2006-11-09 2013-07-03 エムキュア ファーマシューティカルズ リミテッド β遮断薬化合物の改善された調製方法
EP2376452A4 (en) 2009-01-12 2012-08-29 Hetero Research Foundation NEW SULFATE POLYMORPH OF ATAZANAVIR

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1593762A1 (de) * 1967-02-06 1972-06-08 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen substituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen

Also Published As

Publication number Publication date
YU41070A (en) 1978-10-31
YU34281B (en) 1979-04-30
CS153064B2 (en) 1974-02-22
CS153069B2 (es) 1974-02-22
DK135278C (es) 1977-09-12
DK135278B (da) 1977-03-28
YU193675A (en) 1978-10-31
YU34275B (en) 1979-04-30
YU193375A (en) 1978-10-31
BE746107A (fr) 1970-08-17
CS153062B2 (es) 1974-02-22
FI53120B (es) 1977-10-31
PL77781B1 (en) 1975-04-30
AT305249B (de) 1973-02-12
NL162363C (nl) 1980-05-16
JPS5037182B1 (es) 1975-12-01
IL33931A0 (en) 1970-04-20
FR2034561A1 (en) 1970-12-11
CH561175A5 (es) 1975-04-30
CH547257A (de) 1974-03-29
SE391517B (sv) 1977-02-21
PL87019B1 (en) 1976-06-30
CH553747A (de) 1974-09-13
NL162363B (nl) 1979-12-17
SU493062A3 (ru) 1975-11-25
YU34279B (en) 1979-04-30
SU537626A3 (ru) 1976-11-30
DE2007751A1 (es) 1970-09-10
KE2582A (en) 1975-12-05
FR2034561B1 (es) 1974-05-24
AT303005B (de) 1972-11-10
FI53120C (es) 1978-02-10
YU193475A (en) 1978-10-31
YU34278B (en) 1979-04-30
SU482943A3 (ru) 1975-08-30
NO128653B (es) 1973-12-27
ES376788A1 (es) 1972-09-16
JPS535287B1 (es) 1978-02-25
IE34003L (en) 1970-08-21
AT305244B (de) 1973-02-12
IE34003B1 (en) 1975-01-08
CA945172A (en) 1974-04-09
DE2007751C2 (de) 1983-12-15
NL7002414A (es) 1970-08-25
IL33931A (en) 1974-01-14

Similar Documents

Publication Publication Date Title
PL93998B1 (en) Alkanolamine derivatives[ca945172a]
US3712927A (en) Alkanolamine derivatives
US3663607A (en) 1-carbamoylalkyl phenoxy-3-amino-2-propanols
FI61027C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara alkanolaminderivat
US3836671A (en) Alkanolamine derivatives for producing beta-adrenergic blockade
US4081447A (en) 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
US4059622A (en) Alkanolamine derivatives
US3676493A (en) Alkanolamine derivatives
FR2459235A1 (fr) Nouveaux derives de sulfonyl-aniline, leur procede de preparation et leur application therapeutique
DK147068B (da) Analogifremgangsmaade til fremstilling af 1-naphthylmethyl-cinnamyl-aminderivater
US3634511A (en) 1-(4-acylamino-2-alkylphenoxy)-3-amino-2-propanol derivatives
FR2479825A1 (fr) Benzodioxanne 1,4 methoxy-2 propanolamines, leur preparation et leur application en tant que medicaments
Szmuszkovicz et al. A new nontricyclic antidepressant agent. Synthesis and activity of N-[trans-2-dimethylaminocyclopentyl]-N-(3, 4-dichlorophenyl) propanamide and related compounds
US3992446A (en) Substituted aminochlorobenzylamino guanidine compounds
US3574749A (en) 1-(4-amidophenoxy)-3-amino-2-propanol derivatives
SHEPARD et al. PREPARATION OF SOME ANALOGS OF PAPAVERINE1
US3934032A (en) Alkanolamine derivatives for treating hypertension
US4970238A (en) 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
US4167581A (en) Alkanolamine derivatives and pharmaceutical compositions and uses thereof
US3131218A (en) N-amino guanidine derivatives
US3538150A (en) Alkanolamine derivatives
FI67075C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara disubstituerade fenoletrar av 3-amino-2-hydroxipropan och salter daerav
US4431664A (en) Compound with antiulcerogenic activity, process for the preparation thereof and pharmaceutical composition therefrom
PL87015B1 (es)
US3959486A (en) Method for producing β-adrenergic blockage with alkanolamine derivatives